Abstract
Background: Sarcopenia, defined as the progressive and generalized loss of skeletal muscle mass, has been reported in 22-45% of waiting-list cirrhotic patients, with one-year post-liver transplantation (LT) survival rates of 50%-64% in sarcopenics vs 85%-94% in non-sarcopenics. However, its role in organ allocation has never been considered, to reduce the underestimation of MELD in liver disease severity in some categories of patients, as women or elders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
